GV, Google's venture capital arm, led a $30 million Series B funding round for Infinitus Systems, which automates phone calls from healthcare providers to payers.
Innovation
Memphis, Tenn.-based St. Jude Children's Hospital has inked a deal to share deidentified patient data with medical image processing platform developer IQ-AI Limited.
Seattle-based healthcare provider Swedish announced a $20 million personal bequest from the late Paul G. Allen, co-founder of Microsoft, to support the establishment of the Paul G. Allen Research Center at Swedish Cancer Institute, according to a Nov. 9 press…
Charlotte, N.C.-based Atrium Health on Nov. 9 revealed new details about its $1.5 billion innovation district that will surround its future medical school, the Wake Forest University School of Medicine Charlotte, according to The Charlotte Observer.
Tampa General Hospitals' venture arm, TGH InnoVentures, hosted a partners meeting showcasing the program's progress and offered a tour of the new facilities, Tampa Bay, Fla.-based Fox 13 reported Nov. 8.
Truveta, a healthcare data analytics startup formed by 14 U.S. health systems, on Nov. 9 launched its deidentified clinical data platform, which pools information on participating care sites to glean insights on medical conditions such as COVID-19 and rare diseases.
Ohio Gov. Mike DeWine and Lt. Gov. John Husted on Nov. 8 shared updates on the Cleveland Innovation District, which was unveiled in January.
Optum Ventures, Providence Ventures, Kaiser Permanente Ventures and Ascension Ventures have led or joined nearly a dozen funding rounds since the start of 2021 focused on mental health, virtual care and technology-powered optimization.
COVID-19 has driven rapid acceleration of digital transformation at health systems nationwide. Virtual health, remote collaboration and remote patient engagement are now the norm for clinicians. This revolution in healthcare technology, however, isn't without challenges.
Researchers from Cleveland Clinic developed a machine learning tool that predicts whether cancer immunotherapy drugs will be effective for patients, according to a Nov. 1 study published in Nature Biotechnology.